Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 8.14
+0.05 (0.62%)
Apr 17, 2026, 2:00 PM CST
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 3.43 billion as of April 17, 2026. Its market cap has decreased by -49.54% in one year.
Market Cap
3.43B
Enterprise Value
3.30B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.14
Market Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 3.43B, a decrease of -32.85%. That is a compound annual growth rate of -11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.43B | -1.33% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 6.34B |
| LIWANLI Innovation | 6.11B |
| SCI Pharmtech | 5.80B |
| Orient Pharma | 5.75B |
| Easywell Biomedicals | 5.42B |
| Orient EuroPharma | 4.11B |
| Maywufa Company | 2.90B |
| Allied Biotech | 2.65B |